sábado, 16 de septiembre de 2023
FDA Issues Warning Letters to Three Infant Formula Manufacturers
https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-three-infant-formula-manufacturers?utm_medium=email&utm_source=govdelivery
FDA Issues Warning Letters to Three Infant Formula Manufacturers
Actions are Part of Enhanced Oversight; FDA Does Not Advise Discarding or Avoiding Purchase of Any Particular Infant Formula
The U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the safest conditions possible.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario